Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
Chemical Structure : W1131
CAS No.: 2740522-79-4
Catalog No.: PC-38849Not For Human Use, Lab Use Only.
W1131 is a potent and selective STAT3 inhibitor with Kd of 7.55 uM in surface plasmon resonance (SPR) assays, inhibits STAT3 Tyr705 phosphorylation, triggers ferroptosis and possesses potent anti-tumor effects both in vitro and in vivo.
| Packing | Price | Stock | Quantity |
|---|---|---|---|
| 5 mg | $248 | In stock | |
| 10 mg | $398 | In stock | |
| 25 mg | $598 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
W1131 is a potent and selective STAT3 inhibitor with Kd of 7.55 uM in surface plasmon resonance (SPR) assays, inhibits STAT3 Tyr705 phosphorylation, triggers ferroptosis and possesses potent anti-tumor effects both in vitro and in vivo.
W1131 inhibited STAT3 tyrosine phosphorylation and dimerization, accumulation of nuclear pY705-STAT3, and transcriptional activity.
W1131 inhibited STAT3 Tyr705 phosphorylation in a time- and dose-dependent manner without obvious effect on the activation of STAT1 and STAT5, W1131 had no obvious effect on phospho-JAK2 or phospho-AKT levels.
W1131 strongly inhibited cell survival, migration, and invasion, W1131 (1 uM) triggers ferroptosis and inhibited GPX4, SLC7A11, and FTH1 expression in gastric cancer cells.
W1131 (3 mg/kg and 10 mg/kg, i.p.) induced ferroptosis and regressed tumor growth of gastric cancer in vivo.
W1131 also alleviated chemotherapy resistance (5-FU) in multiple models of gastric cancer.
| M.Wt | 429.436 | |
| Formula | C23H19N5O4 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
| Chemical Name/SMILES |
2-Furancarboxamide, 5-nitro-N-[4-[7-(1,2,3,6-tetrahydro-4-pyridinyl)imidazo[1,2-a]pyridin-3-yl]phenyl]- |
|
1. Ouyang S, et al. Redox Biol. 2022 Jun;52:102317.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright
